Lennart Lee serves as Managing Director at WuXi AppTec since 2017, also holding prior roles such as Senior Director and Director in Investments & Strategic Transactions. Concurrently, Lennart Lee is a Board Member and Investor at Insilico Medicine, Simcha Therapeutics, and TenNor Therapeutics, and a Board Member at D3 Bio. Additional leadership roles include Board Observer positions at ShouTi, XWPharma, Magnolia Neurosciences, ApoGen Biotechnologies, Inc., and Proniras Corporation. Educational credentials include a Master's degree in Biotechnology from Columbia University and a Bachelor's degree in Economics from the University of California, Berkeley.